| Vineet Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543298 |
NSE Symbol : VINEETLAB |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE505Y01010 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 15.43 |
Market Cap(₹Cr) : 38.95 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 17.42 | 7.44 | 14.08 | 18.10 | 18.96 | 23.86 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 17.42 | 7.44 | 14.08 | 18.10 | 18.96 | 23.86 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.01 | 0.02 | 1.38 | 0.03 | 0.20 | 0.37 |
| Total Income | 17.43 | 7.46 | 15.46 | 18.13 | 19.16 | 24.23 |
| Total Expenditure | 14.24 | 7.12 | 25.12 | 22.24 | 19.26 | 24.66 |
| PBIDT | 3.18 | 0.34 | -9.66 | -4.10 | -0.11 | -0.42 |
| Interest | 2.19 | 0.61 | 0.90 | 0.95 | 0.99 | 1.14 |
| PBDT | 1.00 | -0.28 | -10.56 | -5.05 | -1.10 | -1.56 |
| Depreciation | 0.63 | 0.63 | 0.66 | 0.62 | 0.62 | 0.61 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.03 | -0.04 | -0.70 | 0.03 | 0.12 | -0.04 |
| Reported Profit After Tax | 0.40 | -0.87 | -10.53 | -5.71 | -1.83 | -2.13 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.40 | -0.87 | -10.53 | -5.71 | -1.83 | -2.13 |
| EPS (Unit Curr.) | 0.43 | -0.94 | -11.42 | -6.19 | -1.98 | -2.31 |
| EPS (Adj) (Unit Curr.) | 0.43 | -0.94 | -11.42 | -6.19 | -1.98 | -2.31 |
| Calculated EPS (Unit Curr.) | 0.43 | -0.94 | -11.42 | -6.19 | -1.98 | -2.31 |
| Calculated EPS (Adj) (Unit Curr.) | 0.43 | -0.94 | -11.42 | -6.19 | -1.98 | -2.31 |
| Calculated EPS (Ann.) (Unit Curr.) | 1.74 | -3.76 | -45.67 | -24.76 | -7.93 | -9.24 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 1.74 | -3.76 | -45.67 | -24.76 | -7.93 | -9.24 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 9.22 | 9.22 | 9.22 | 9.22 | 9.22 | 9.22 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 18.25 | 4.57 | -68.61 | -22.65 | -0.58 | -1.76 |
| PBDTM(%) | 5.74 | -3.76 | -75.00 | -27.90 | -5.80 | -6.54 |
| PATM(%) | 2.30 | -11.69 | -74.79 | -31.55 | -9.65 | -8.93 |